Literature DB >> 12802280

Inactivation of hTERT transcription by Tax.

Anne-Sophie Gabet1, Franck Mortreux, Pierre Charneau, Patrice Riou, Madeleine Duc-Dodon, Yalin Wu, Kuan-Teh Jeang, Eric Wattel.   

Abstract

Telomerase expression is the hallmark of tumor cells in which this ribonucleoprotein complex preserves chromosome integrity by maintaining telomere length and thereby prevents cell death. However, recent data support a role of the combination of p53 and telomerase inactivation in initiating genetic instability that promotes malignant transformation. Through its pleiotropic effects on infected T-cell metabolism, the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein Tax plays a central role in leukemogenesis. Here, we show that Tax inhibits human telomerase reverse transcriptase (hTERT) transcription, which is the rate-limiting factor of telomerase activity. This inhibitory effect, that occurs in competition with c-Myc through a canonical c-Myc binding site within the hTERT promoter, results in a decreased telomerase activity of Tax-expressing cells. This is the first demonstration of hTERT inhibition by an oncogene. Tax, which is only expressed in preleukemic cells, triggers infected T-cell cycle and keeps these cells cycling while inactivating p53. We propose that, in combination with these effects, hTERT repression by Tax at an early phase of carcinogenesis might contribute to the massive ploidy changes associated with the development of HTLV-1-associated malignancies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802280     DOI: 10.1038/sj.onc.1206468

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  HTLV-1 propels untransformed CD4 lymphocytes into the cell cycle while protecting CD8 cells from death.

Authors:  David Sibon; Anne-Sophie Gabet; Marc Zandecki; Christiane Pinatel; Julien Thête; Marie-Hélène Delfau-Larue; Samira Rabaaoui; Antoine Gessain; Olivier Gout; Steven Jacobson; Franck Mortreux; Eric Wattel
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

2.  Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.

Authors:  Maroun Karam; Morgan Thenoz; Valérie Capraro; Jean-Philippe Robin; Christiane Pinatel; Agnès Lancon; Perrine Galia; David Sibon; Xavier Thomas; Sophie Ducastelle-Lepretre; Franck Nicolini; Mohamed El-Hamri; Youcef Chelghoun; Eric Wattel; Franck Mortreux
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

3.  Acetylation of the c-MYC oncoprotein is required for cooperation with the HTLV-1 p30(II) accessory protein and the induction of oncogenic cellular transformation by p30(II)/c-MYC.

Authors:  Megan M Romeo; Bookyung Ko; Janice Kim; Rebecca Brady; Hayley C Heatley; Jeffrey He; Carolyn K Harrod; Braden Barnett; Lee Ratner; Michael D Lairmore; Ernest Martinez; Bernhard Lüscher; Craig N Robson; Marie Henriksson; Robert Harrod
Journal:  Virology       Date:  2015-01-05       Impact factor: 3.616

4.  Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.

Authors:  Marcia Bellon; Christophe Nicot
Journal:  Int J Cancer Oncol       Date:  2015-06-02

Review 5.  The telomerase cycle: normal and pathological aspects.

Authors:  Michele Brunori; Pierre Luciano; Eric Gilson; Vincent Géli
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

6.  Identification of PITX1 as a TERT suppressor gene located on human chromosome 5.

Authors:  Dong-Lai Qi; Takahito Ohhira; Chikako Fujisaki; Toshiaki Inoue; Tsutomu Ohta; Mitsuhiko Osaki; Eriko Ohshiro; Tomomi Seko; Shinsuke Aoki; Mitsuo Oshimura; Hiroyuki Kugoh
Journal:  Mol Cell Biol       Date:  2011-02-07       Impact factor: 4.272

Review 7.  Human T-cell leukemia virus type 1 Tax and cellular transformation.

Authors:  Jean-Marie Peloponese; Takao Kinjo; Kuan-Teh Jeang
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

8.  Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo.

Authors:  Linda Zane; David Sibon; Lionel Jeannin; Marc Zandecki; Marie-Hélène Delfau-Larue; Antoine Gessain; Olivier Gout; Christiane Pinatel; Agnès Lançon; Franck Mortreux; Eric Wattel
Journal:  Retrovirology       Date:  2010-03-11       Impact factor: 4.602

9.  Ubiquitination of human T-cell leukemia virus type 1 tax modulates its activity.

Authors:  Jean-Marie Peloponese; Hidekatsu Iha; Venkat R K Yedavalli; Akiko Miyazato; Yan Li; Kerstin Haller; Monsef Benkirane; Kuan-Teh Jeang
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 10.  Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma.

Authors:  G Taylor
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.